Skip to main content
. 2016 Mar 29;63(1):115–121. doi: 10.1093/cid/ciw190

Table 1.

Estimated Numbers of Patients With Human Immunodeficiency Virus (HIV)/AIDS in 2013 and Engagement in the HIV Care Continuum by Demographic Characteristics, Shandong Province, China

Characteristic Unaware No. (Cumulative %)
Diagnosis Linkage Retention Eligible for HAART On HAART Viral Suppression P Value
Sex
 Male (n = 5550 [range, 3900–7200]) 2332 3218* (58.0) 2741 (49.4) 2219* (40.0) 1451* (26.1) 1327* (23.9) 760* (13.7) **
 Female (n = 950 [range, 700–1200]) 261 689 (72.5) 497 (52.3) 416 (43.8) 325 (34.2) 310 (32.6) 215 (22.6) a
Transmission mode
 Blood donation/transfusion (n = 260 [range, 180–340]) 39 221* (85.0) 143* (55.0) 133* (51.2) 125* (48.1) 122* (46.9) 97* (37.3) a
 Homosexual (n = 3810 [range, 2700–4920]) 1930 1880 (49.3) 1745 (45.8) 1428 (37.5) 846 (22.2) 770 (20.2) 432 (11.3) **
 IDU (n = 190 [range, 130–250]) 42 148 (77.9) 85 (44.7) 58 (50.5) 48 (25.3) 35 (18.4) 20 (10.5) **
 Heterosexual (n = 2050 [range, 1450–2650]) 568 1482 (72.3) 1173 (57.2) 948 (46.2) 712 (34.7) 666 (32.5) 406 (19.8) **
MTCT (n = 190 [range, 130–250]) 14 176 (92.6) 92 (48.4) 68 (35.8) 45 (23.7) 44 (23.2) 20 (10.5) **
Age at entry to care
 <15 y 176 92* (52.3) 68* (38.6) 45* (25.6) 44* (25.0) 20* (11.4) **
 15–24 y 846 784 (92.7) 580 (68.6) 330 (39.0) 286 (33.8) 166 (19.6) **
 25–34 y 1465 1214 (82.9) 984 (67.2) 626 (42.7) 581 (39.7) 363 (24.8)
 35–44 y 960 770 (80.2) 677 (70.5) 514 (53.5) 487 (50.7) 284 (29.6)
 45–54 y 329 261 (79.3) 227 (69.0) 180 (54.7) 165 (50.2) 99 (30.1)
 ≥55 y 131 117 (89.3) 99 (75.6) 81 (61.8) 74 (56.5) 43 (32.8) a
Education
 Illiterate 258 156* (60.5) 124* (48.1) 95* (36.8) 88* (34.1) 50* (19.4) a
 Primary 505 353 (69.9) 290 (57.4) 236 (46.7) 219 (43.4) 139 (27.5)
 Junior middle 1166 960 (82.3) 783 (67.2) 568 (48.7) 533 (45.7) 322 (27.6)
 Junior high 948 834 (88.0) 674 (71.1) 428 (45.1) 385 (40.6) 237 (25.0)
 College or greater 1030 935 (90.8) 764 (74.2) 449 (43.6) 412 (40.0) 227 (22.0)
Testing venue
 Medical facility 1166 1014* (87.0) 849* (72.8) 634* (54.4) 595* (51.0) 359* (30.8) a
 VCT 2444 2041 (83.5) 1656 (67.8) 1045 (42.8) 959 (39.2) 563 (23.0) **
 Custody institution 177 94 (53.1) 57 (32.2) 44 (24.9) 32 (18.1) 16 (9.0) **
 Other 120 89 (74.2) 73 (60.8) 53 (44.2) 51 (42.5) 37 (30.8)

For sex and transmission, the total number of infected persons was used as the denominator when calculating cumulative percentages for each stage in the continuum. For age at entry to care, education, and testing venue, the total number diagnosed was used as the denominator for subsequent stages.

Abbreviations: HAART, highly active antiretroviral therapy; IDU, intravenous drug user; MTCT, mother-to-child transmission; VCT, voluntary counseling and testing.

a Reference category for partition of χ2 test in the step of achieving viral suppression.

*P < .05 for χ2 test in each step of HIV care.

**P < ά for partition of χ2 test, ά = .00625 for transmission mode and education, ά = .001 for age at entry, ά = .0083 for testing venue.